US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GRAIL, Inc.

143.26

+10.708.07%

Post-market: 141.45-1.8100-1.26%19:40 EDT

Volume:875.23K

Turnover:123.24M

Market Cap:6.40B

PE:-14.70

High:143.50

Open:135.52

Low:134.45

Close:132.56

52wk High:151.46

52wk Low:41.50

Shares:44.67M

Float Shares:40.70M

Volume Ratio:0.69

T/O Rate:2.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.7487

EPS(LYR):-11.1105

ROE:-16.12%

ROA:-12.03%

PB:2.52

PE(LYR):-12.89

Loading ...

Overview Company News Filings

UBS Adjusts GRAIL Price Target to $175 From $105, Maintains Buy Rating

MT Newswires Live

Movement Alert｜GRAIL, Inc. Rises 6% in Regular Trading, FDA Advisory Committee Favorable Vote Continues to Drive Stock Rebound

Grail Inc : UBS Raises Target Price to $175 from $105

THOMSON REUTERS

Grail's Cancer Blood Test Nears Landmark FDA Approval, but Insurance Coverage Looms

Movement Alert｜GRAIL, Inc. Falls 5.07% in Regular Trading, Post-FDA Advisory Committee Rally Triggers Profit-Taking

Grail price target raised to $155 from $75 at Guggenheim

A Cancer Test Has Investors Betting Big. but Will Insurers Pay? - Heard on the Street

Movement Alert｜GRAIL, Inc. Rises 5.27% in Regular Trading, FDA Advisory Committee Unanimously Approves Galleri Safety and Supports Approval

Movement Alert｜GRAIL, Inc. Rises 5.69% in Regular Trading, FDA Advisory Committee Votes in Favor of Galleri Multi-Cancer Detection Test

Grail is Maintained at Buy by Canaccord Genuity

Grail price target raised to $150 from $80 at Canaccord

U.S. Research Roundup-Chevron, Mobility Global, Tesla

Grail Inc : Canaccord Genuity Raises Target Price to $150 from $80

THOMSON REUTERS

Canaccord Genuity Keeps Their Buy Rating on GRAIL Inc (GRAL)

Grail price target raised to $100 from $65 at Mizuho

US Research Roundup-Chevron, Exxon Mobil, GoDaddy

Grail Shares Gain as FDA Panel Votes to Support Cancer Detection Test

FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.

Movement Alert｜GRAIL, Inc. Rises 5.97% in Regular Trading, FDA Advisory Committee Votes in Favor of Galleri Cancer Detection Test Approval

TD ups Grail approval probability to 95% after panel vote

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/GRAL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":143.26,"timestamp":1790971200000,"preClose":132.56,"halted":0,"volume":875232,"hourTrading":{"tag":"盘后","latestPrice":141.45,"preClose":143.26,"latestTime":"19:40 EDT","volume":22273,"amount":3188412.4685799996,"timestamp":1790984436993,"change":-1.81,"changeRate":-0.012634,"amplitude":0.016404},"delay":0,"changeRate":0.08071816535908259,"floatShares":40696402,"shares":44666200,"eps":-9.748709,"marketStatus":"Post-Mkt","change":10.7,"latestTime":"10-02 19:50:45 EDT","open":135.52,"high":143.5,"low":134.45,"amount":123241225.36896,"amplitude":0.068271,"askPrice":145,"askSize":1,"bidPrice":141.44,"bidSize":111,"shortable":3,"etf":0,"ttmEps":-9.748709,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":132.56,"preHourTrading":{"tag":"盘前","latestPrice":135.7719,"preClose":132.56,"latestTime":"09:24 EDT","volume":1153,"amount":155671.68391,"timestamp":1790947487905,"change":3.2119,"changeRate":0.02423,"amplitude":0.049487},"postHourTrading":{"tag":"盘后","latestPrice":141.45,"preClose":143.26,"latestTime":"19:40 EDT","volume":22273,"amount":3188412.4685799996,"timestamp":1790984436993,"change":-1.81,"changeRate":-0.012634,"amplitude":0.016404},"volumeRatio":0.69029,"impliedVol":0.8636,"impliedVolPercentile":0.2032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":40696402,"roa":"-12.03%","roe":"-16.12%","lyrEps":-11.110457,"volumeRatio":0.69029,"shares":44666200,"dividePrice":0,"high":143.5,"amplitude":0.068271,"preClose":132.56,"low":134.45,"week52Low":41.5,"pbRate":"2.52","psRate":"38.72","week52High":151.4574,"institutionHeld":0,"latestPrice":143.26,"committee":0.982143,"eps":-9.748709,"divideRate":0,"volume":875232,"delay":0,"ttmEps":-9.748709,"open":135.52,"prevYearClose":85.59,"prevWeekClose":126.89,"prevMonthClose":140.12,"prevQuarterClose":140.12,"fiveDayClose":126.89,"twentyDayClose":80.62,"sixtyDayClose":75.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"GRAL","fiscalQuarterEnding":"2026/06","expectedEps":-2.91,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-2.56},{"market":"US","date":"2026-05-05","symbol":"GRAL","fiscalQuarterEnding":"2026/03","expectedEps":3,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2026-02-19","symbol":"GRAL","fiscalQuarterEnding":"2025/12","expectedEps":-3.33,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2025-11-12","symbol":"GRAL","fiscalQuarterEnding":"2025/09","expectedEps":-3.4,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-2.46},{"market":"US","date":"2025-08-12","symbol":"GRAL","fiscalQuarterEnding":"2025/06","expectedEps":-3.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-3.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1818,"buy":0.2727,"hold":0.5455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2727,"analysts":11,"updateTime":1789704000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2026-10-01","current":-14.695279,"percent":0,"low":-15.982739,"twenty":-7.790286,"median":-2.679464,"eighty":-0.304176,"high":-0.135365,"avg":-3.853415,"sd":3.754563,"marketCap":6258632708},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278},{"date":"2025-06-13","current":-0.787758,"twenty":-0.602918,"median":-0.308322,"eighty":-0.156041,"marketCap":1508008868},{"date":"2025-06-20","current":-0.910282,"twenty":-0.617043,"median":-0.310838,"eighty":-0.156127,"marketCap":1742556049},{"date":"2025-06-27","current":-0.927946,"twenty":-0.628237,"median":-0.313683,"eighty":-0.156967,"marketCap":1776371133},{"date":"2025-07-03","current":-0.87796,"twenty":-0.640897,"median":-0.324667,"eighty":-0.158949,"marketCap":1680681639},{"date":"2025-07-11","current":-0.815382,"twenty":-0.656882,"median":-0.33641,"eighty":-0.159595,"marketCap":1560889904},{"date":"2025-07-18","current":-0.675007,"twenty":-0.694504,"median":-0.351643,"eighty":-0.160456,"marketCap":1292167904},{"date":"2025-07-25","current":-0.746416,"twenty":-0.703946,"median":-0.35847,"eighty":-0.160672,"marketCap":1428867181},{"date":"2025-08-01","current":-0.642872,"twenty":-0.704698,"median":-0.372061,"eighty":-0.161318,"marketCap":1230653229},{"date":"2025-08-08","current":-0.619382,"twenty":-0.703946,"median":-0.384644,"eighty":-0.164764,"marketCap":1185686362},{"date":"2025-08-15","current":-2.618835,"twenty":-0.718416,"median":-0.412102,"eighty":-0.165733,"marketCap":1160018171},{"date":"2025-08-22","current":-2.697774,"twenty":-0.721799,"median":-0.415789,"eighty":-0.165949,"marketCap":1194984536},{"date":"2025-08-29","current":-2.7759,"twenty":-0.732698,"median":-0.419718,"eighty":-0.170579,"marketCap":1229590423},{"date":"2025-09-05","current":-2.733582,"twenty":-0.742958,"median":-0.427076,"eighty":-0.170837,"marketCap":1210845568},{"date":"2025-09-12","current":-3.145369,"twenty":-0.751941,"median":-0.435395,"eighty":-0.172539,"marketCap":1393247431},{"date":"2025-09-19","current":-3.221867,"twenty":-0.757193,"median":-0.443129,"eighty":-0.177083,"marketCap":1427132362},{"date":"2025-09-26","current":-3.927439,"twenty":-0.772199,"median":-0.450236,"eighty":-0.179927,"marketCap":1739666779},{"date":"2025-10-03","current":-5.267781,"twenty":-0.790326,"median":-0.453995,"eighty":-0.180724,"marketCap":2333374029},{"date":"2025-10-10","current":-5.788618,"twenty":-0.792794,"median":-0.466707,"eighty":-0.18193,"marketCap":2564079942},{"date":"2025-10-17","current":-7.032117,"twenty":-0.810572,"median":-0.474733,"eighty":-0.214168,"marketCap":3114890311},{"date":"2025-10-24","current":-6.726125,"twenty":-0.834423,"median":-0.483801,"eighty":-0.232186,"marketCap":2979350587},{"date":"2025-10-31","current":-7.417862,"twenty":-0.86879,"median":-0.497307,"eighty":-0.23482,"marketCap":3285756878},{"date":"2025-11-07","current":-6.515349,"twenty":-0.90953,"median":-0.508594,"eighty":-0.23627,"marketCap":2885986787},{"date":"2025-11-14","current":-7.32206,"twenty":-1.284423,"median":-0.515869,"eighty":-0.238888,"marketCap":3243320953},{"date":"2025-11-21","current":-8.218834,"twenty":-2.622741,"median":-0.524768,"eighty":-0.242438,"marketCap":3338827399},{"date":"2025-11-28","current":-10.592844,"twenty":-2.668803,"median":-0.533066,"eighty":-0.245748,"marketCap":4303247596},{"date":"2025-12-05","current":-10.047321,"twenty":-2.733908,"median":-0.545714,"eighty":-0.248685,"marketCap":4081633659},{"date":"2025-12-12","current":-9.121802,"twenty":-2.773947,"median":-0.559678,"eighty":-0.249586,"marketCap":3705650118},{"date":"2025-12-19","current":-8.474563,"twenty":-3.023948,"median":-0.565758,"eighty":-0.250383,"marketCap":3442715024},{"date":"2025-12-26","current":-8.814736,"twenty":-3.115583,"median":-0.600672,"eighty":-0.254281,"marketCap":3580907004},{"date":"2026-01-02","current":-8.213077,"twenty":-3.191837,"median":-0.607471,"eighty":-0.259493,"marketCap":3336488466},{"date":"2026-01-09","current":-9.407758,"twenty":-3.756539,"median":-0.615248,"eighty":-0.260321,"marketCap":3821817142},{"date":"2026-01-16","current":-9.350183,"twenty":-4.63773,"median":-0.618067,"eighty":-0.262044,"marketCap":3798427809},{"date":"2026-01-23","current":-11.136928,"twenty":-5.050494,"median":-0.621638,"eighty":-0.262589,"marketCap":4524276801},{"date":"2026-01-30","current":-9.689876,"twenty":-5.381714,"median":-0.623725,"eighty":-0.263657,"marketCap":3936424878},{"date":"2026-02-06","current":-9.025844,"twenty":-5.92371,"median":-0.62862,"eighty":-0.266328,"marketCap":3666667895},{"date":"2026-02-13","current":-9.201448,"twenty":-6.490935,"median":-0.634416,"eighty":-0.269888,"marketCap":3738005363},{"date":"2026-02-20","current":-10.027753,"twenty":-6.738169,"median":-0.640672,"eighty":-0.270458,"marketCap":4094842980},{"date":"2026-02-27","current":-5.738328,"twenty":-6.59852,"median":-0.642551,"eighty":-0.271707,"marketCap":2343252016},{"date":"2026-03-06","current":-5.1161,"twenty":-6.525603,"median":-0.645131,"eighty":-0.273298,"marketCap":2089164448},{"date":"2026-03-13","current":-4.454105,"twenty":-6.495818,"median":-0.656882,"eighty":-0.273627,"marketCap":1818838106},{"date":"2026-03-20","current":-4.868977,"twenty":-6.467497,"median":-0.678025,"eighty":-0.275336,"marketCap":1988251759},{"date":"2026-03-27","current":-5.23965,"twenty":-6.370491,"median":-0.694504,"eighty":-0.275763,"marketCap":2139616500},{"date":"2026-04-02","current":-5.384303,"twenty":-6.22661,"median":-0.703946,"eighty":-0.276019,"marketCap":2198685668},{"date":"2026-04-10","current":-4.777565,"twenty":-6.012578,"median":-0.718792,"eighty":-0.276332,"marketCap":1950923327},{"date":"2026-04-17","current":-4.969431,"twenty":-5.842655,"median":-0.720859,"eighty":-0.277189,"marketCap":2029272014},{"date":"2026-04-24","current":-5.087966,"twenty":-5.758444,"median":-0.724241,"eighty":-0.277697,"marketCap":2077675915},{"date":"2026-05-01","current":-5.472702,"twenty":-5.73481,"median":-0.732698,"eighty":-0.277887,"marketCap":2234783492},{"date":"2026-05-08","current":-6.830613,"twenty":-5.758444,"median":-0.740497,"eighty":-0.278585,"marketCap":2700312031},{"date":"2026-05-15","current":-6.709025,"twenty":-6.393277,"median":-0.747877,"eighty":-0.279728,"marketCap":2652245447},{"date":"2026-05-22","current":-7.366901,"twenty":-6.535065,"median":-0.752054,"eighty":-0.280426,"marketCap":2912320000},{"date":"2026-05-29","current":-8.024776,"twenty":-6.608933,"median":-0.75506,"eighty":-0.280871,"marketCap":3172394554},{"date":"2026-06-05","current":-7.224687,"twenty":-6.675155,"median":-0.757458,"eighty":-0.282109,"marketCap":2856099264},{"date":"2026-06-12","current":-6.530986,"twenty":-6.667338,"median":-0.770188,"eighty":-0.283378,"marketCap":2581862234},{"date":"2026-06-18","current":-6.453909,"twenty":-6.64758,"median":-0.774322,"eighty":-0.283727,"marketCap":2551391453},{"date":"2026-06-26","current":-7.226858,"twenty":-6.705551,"median":-0.790201,"eighty":-0.284901,"marketCap":2856957596},{"date":"2026-07-02","current":-7.394041,"twenty":-6.741593,"median":-0.791697,"eighty":-0.287059,"marketCap":2923049149},{"date":"2026-07-10","current":-8.227784,"twenty":-6.830613,"median":-0.793866,"eighty":-0.287218,"marketCap":3252648583},{"date":"2026-07-17","current":-7.811998,"twenty":-6.920316,"median":-0.805047,"eighty":-0.287691,"marketCap":3088278032},{"date":"2026-07-24","current":-7.638301,"twenty":-7.010823,"median":-0.819893,"eighty":-0.291185,"marketCap":3019611483},{"date":"2026-07-31","current":-7.722978,"twenty":-7.028862,"median":-0.830133,"eighty":-0.292962,"marketCap":3053086426},{"date":"2026-08-07","current":-7.231699,"twenty":-7.225121,"median":-0.842819,"eighty":-0.294422,"marketCap":2831839235},{"date":"2026-08-14","current":-7.783772,"twenty":-7.278539,"median":-0.870399,"eighty":-0.295212,"marketCap":3048023808},{"date":"2026-08-21","current":-8.893621,"twenty":-7.372329,"median":-0.87796,"eighty":-0.295699,"marketCap":3482626264},{"date":"2026-08-28","current":-9.410334,"twenty":-7.428129,"median":-0.917705,"eighty":-0.296146,"marketCap":3684964305},{"date":"2026-09-04","current":-9.195892,"twenty":-7.480979,"median":-0.966282,"eighty":-0.297019,"marketCap":3600991785},{"date":"2026-09-11","current":-8.846854,"twenty":-7.492831,"median":-2.572448,"eighty":-0.297976,"marketCap":3464313109},{"date":"2026-09-18","current":-9.119469,"twenty":-7.639447,"median":-2.628601,"eighty":-0.298484,"marketCap":3571065408},{"date":"2026-09-25","current":-14.282035,"twenty":-7.746291,"median":-2.668477,"eighty":-0.301515,"marketCap":5592659159},{"date":"2026-10-01","current":-15.982739,"twenty":-7.790286,"median":-2.679464,"eighty":-0.304176,"marketCap":6258632708}],"updateTime":1790985045910},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672717206","title":"UBS Adjusts GRAIL Price Target to $175 From $105, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672717206","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672717206?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:08","pubTimestamp":1790950114,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) has an average rating of overweight and mean price target of $77.70, according to analysts polled by FactSet.Price: 140.34, Change: +7.78, Percent Change: +5.87","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181820957","title":"Movement Alert｜GRAIL, Inc. Rises 6% in Regular Trading, FDA Advisory Committee Favorable Vote Continues to Drive Stock Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1181820957","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181820957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:47","pubTimestamp":1790948868,"startTime":"0","endTime":"0","summary":"On October 2, GRAIL, Inc. rose 6% in regular trading, trading at $139.29 per share, with turnover of $10.37 million. The stock had briefly dipped earlier in the session on short-term profit-taking...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GRAIL Rises as FDA Panel Backs Galleri Test","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712248","title":"Grail Inc : UBS Raises Target Price to $175 from $105","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712248?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:22","pubTimestamp":1790947354,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nAZN4TN6TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711341","title":"Grail's Cancer Blood Test Nears Landmark FDA Approval, but Insurance Coverage Looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711341","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711341?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:46","pubTimestamp":1790941578,"startTime":"0","endTime":"0","summary":"Grail's cancer blood test nears landmark FDA approval, but insurance coverage loomsOct 2 (Reuters)-An advisory panel to the US Food and Drug Administration handed Grail'sGRAL.OGalleri blood test a mil","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N3YL0SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136135408","title":"Movement Alert｜GRAIL, Inc. Falls 5.07% in Regular Trading, Post-FDA Advisory Committee Rally Triggers Profit-Taking","url":"https://stock-news.laohu8.com/highlight/detail?id=1136135408","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136135408?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:56","pubTimestamp":1790884590,"startTime":"0","endTime":"0","summary":"On October 2, GRAIL, Inc. fell 5.07% in regular trading, trading around $132.38/share, with turnover of approximately $121 million. The decline came as short-term profit-taking pressure emerged...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"GRAIL Falls on Profit-Taking After FDA Panel Rally","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672575209","title":"Grail price target raised to $155 from $75 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2672575209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672575209?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:37","pubTimestamp":1790858254,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Grail (GRAL) to $155 from $75 and keeps a Buy rating on the shares. The firm adjusted its models and f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-155-from-75-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-155-from-75-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672975598","title":"A Cancer Test Has Investors Betting Big. but Will Insurers Pay? - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2672975598","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672975598?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:30","pubTimestamp":1790847000,"startTime":"0","endTime":"0","summary":"The FDA itself asked its advisers whether calling it an \"early\" detection test was justified.Being sure of the clinical utility of the test is important because screening healthy people carries risks. A false positive can send someone into scans and biopsies they never needed. A false negative can create false reassurance.The question is whether those risks are justified by the fact that some people will find their cancer earlier. The FDA usually follows its advisory panels, so approval now looks likely. The bigger commercial prize is insurance coverage, particularly Medicare.A law passed this year created a pathway for Medicare to cover multi-cancer screening tests starting as early as 2029. But it didn't guarantee payment. The Centers for Medicare and Medicaid Services  still has to decide whether a test is reasonable and necessary.On Wolfe Research's model, Grail's stock is worth about $50 without Medicare coverage and $150 with it. With the stock trading ar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4211","LU2346227817.USD","ISBC","LU1894683264.USD","LU2500361329.USD","BK4139","BK4585","LU0949170772.SGD","GRAL","LU0545039389.USD","LU1003077747.HKD","LU0738911758.USD","BK4588","LU0661504455.SGD","CMS","LU2637428348.USD","LU0553294199.USD","BK4208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142437486","title":"Movement Alert｜GRAIL, Inc. Rises 5.27% in Regular Trading, FDA Advisory Committee Unanimously Approves Galleri Safety and Supports Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1142437486","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142437486?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:07","pubTimestamp":1790777250,"startTime":"0","endTime":"0","summary":"On September 30, GRAIL, Inc. rose 5.27% in regular trading, trading at $144.035 per share, with turnover of $24.4235 million. The stock extended its recent upward momentum following the FDA Molecular...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GRAIL Surges as FDA Panel Unanimously Backs Galleri Safety","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122238451","title":"Movement Alert｜GRAIL, Inc. Rises 5.69% in Regular Trading, FDA Advisory Committee Votes in Favor of Galleri Multi-Cancer Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=1122238451","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122238451?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:46","pubTimestamp":1790603170,"startTime":"0","endTime":"0","summary":"On September 28, GRAIL, Inc. rose 5.69% in regular trading, trading at $130.05 per share, with turnover of $17.95 million. The stock extended its recent uptrend following a landmark vote by the FDA...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FDA Panel Backs Galleri, UBS Keeps Buy","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237081","title":"Grail is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237081","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237081?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:50","pubTimestamp":1790599800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670806622","title":"Grail price target raised to $150 from $80 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2670806622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670806622?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:30","pubTimestamp":1790584207,"startTime":"0","endTime":"0","summary":"Canaccord analyst Kyle Mikson raised the firm’s price target on Grail (GRAL) to $150 from $80 and keeps a Buy rating on the shares. The firm increa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-150-from-80-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-150-from-80-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670284975","title":"U.S. Research Roundup-Chevron, Mobility Global, Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2670284975","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670284975?lang=en_us&edition=fundamental","pubTime":"2026-09-28 15:19","pubTimestamp":1790579984,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Chevron, Mobility Global, TeslaSept 28 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Chevron, Mobili","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAL","MHIP","ACHC","HXL","DRLL","FUL","GRAL","CWEN","COST","ACET","JETS","CMC","ARE","GGLS","BL","BP","CSTM","AZO","FISV","GGLL","AYI","FSLR","IYH","DTE","DIG","VOX","SETM","PUI","CRL","AA","GPI","CVX","LLY","STZ","DAL","ENPH","BROS","CENX","KO","NVST","AKAM","TAN","ALK","FCX","TXG","COF","EAF","GOOGL","XOM","ADSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670328307","title":"Grail Inc : Canaccord Genuity Raises Target Price to $150 from $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2670328307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670328307?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:11","pubTimestamp":1790568709,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I0HX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670283963","title":"Canaccord Genuity Keeps Their Buy Rating on GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670283963","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670283963?lang=en_us&edition=fundamental","pubTime":"2026-09-28 11:35","pubTimestamp":1790566512,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Kyle Mikson CFA reiterated a Buy rating on GRAIL Inc today and set a price target of $150.00. Mikson CFA covers the Healt...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-grail-inc-gral-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-grail-inc-gral-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442202","title":"Grail price target raised to $100 from $65 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442202?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:36","pubTimestamp":1790336163,"startTime":"0","endTime":"0","summary":"Mizuho raised the firm’s price target on Grail (GRAL) to $100 from $65 and keeps a Neutral rating on the shares. The FDA panel voted that Galleri i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-100-from-65-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-100-from-65-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","GRAL","LABU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670412443","title":"US Research Roundup-Chevron, Exxon Mobil, GoDaddy","url":"https://stock-news.laohu8.com/highlight/detail?id=2670412443","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670412443?lang=en_us&edition=fundamental","pubTime":"2026-09-25 14:58","pubTimestamp":1790319529,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddySept 25 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Chevron, Exxon Mobi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H0CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL","CNK","CVX","NTRA","UGE","PYPL","BNY","CPT","OBK","GXPE","HELX","GEN","CGEM","ANDG","CMCSA","GPOR","KMX","EMR","OKTA","CF","MMM","OILT","XOM","INFQ","AXGN","FSTA","DMRA","AKAM","RSPC","ACAD","META","CDNL","KNF","FUL","UPW","TRUC","LMRI","GRAL","COST","FFBC","P","TRUN","SO","CRK","XLP","ALM","DRI","STZ","GDDY","AEE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492599","title":"Grail Shares Gain as FDA Panel Votes to Support Cancer Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492599","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492599?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:22","pubTimestamp":1790266920,"startTime":"0","endTime":"0","summary":"Shares of Grail rose after the healthcare company said a U.S. regulatory committee voted to approve its Galleri multi-cancer early detection test.The stock was up 5.6% at $114.59 as of midday Thursday. Shares have risen 34% this year.The company on Wednesday said a panel on the Food and Drug Administration's Medical Devices Advisory Committee voted to approve its premarket approval application for Galleri.The panel voted seven to two with one abstention that the test's benefits outweigh its risks, six to four that the test was effective, and unanimously in support of its safety.\"Today's vote reinforces the strength of Galleri's clinical evidence. We believe the panel's recommendations reaffirm a high evidence bar that GRAIL has set for a multi-cancer early detection test,\" Grail Chief Executive Josh Ofman said. \"GRAIL is committed to working with the FDA as it completes its review of Galleri, the first PMA submission for a multi-cancer early detection test.\"Galleri received a breakthro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","LABU","GRAL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499070","title":"FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499070","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499070?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:52","pubTimestamp":1790261520,"startTime":"0","endTime":"0","summary":"Mizuho's Bradley Bowers thinks the boost will be substantial. He wrote Tuesday that sales doubled in the launch years of other cancer-screening products-like colon cancer stool test Cologuard from the Exact Sciences unit of Abbott, or the colon cancer blood test Shield from Guardant Health.Galleri screens a person's blood sample for bits of DNA showing features typical of cancer cells. It tells you if it has found a general signal of cancer somewhere in your body-\"Cancer Signal Detected\"-and makes its best guess at the kind of tissue where the cancer is hiding.Clinical trials showed Galleri can detect cancers for which there is no standard screen, such as cancer of the ovary or pancreas. Grail's two big clinical trials showed that it rarely tells you that you have cancer when you don't. When you do have cancer, the test finds it on average about 50% of the 60% of the time.That is good performance, compared with other widely used screens, like the mammogram. Grail plans to tell customer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4196","LFSC","BK4551","BK4082","ABT","LU0122379950.USD","TMED","LABU","LU1061106388.HKD","BK4585","LU2089984988.USD","FFOX","LU1721429402.USD","BK4588","LU1989763690.USD","SGXZ23171101.USD","LU0889565916.HKD","SG9999004303.SGD","LU2112291526.USD","BK4581","GNMX","LU1691799644.USD","SGXZ41872573.SGD","LU0868494617.USD","PJP","LU1670627923.USD","BK4568","LU0320765489.SGD","IE0002141913.USD","LU2468319806.SGD","GRAL","GH","SG9999002232.USD","EKG","HELX","LU1721429741.USD","BK4139","SG9999002224.SGD","LU2237957811.SGD","LU0289739699.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0211331839.USD","PTH","GNOM","LU0882574055.USD","BK4535","IHI","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172071504","title":"Movement Alert｜GRAIL, Inc. Rises 5.97% in Regular Trading, FDA Advisory Committee Votes in Favor of Galleri Cancer Detection Test Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1172071504","media":"Market Focus","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172071504?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:58","pubTimestamp":1790258338,"startTime":"0","endTime":"0","summary":"On September 24, GRAIL, Inc. rose 5.97% in regular trading, trading at $114.925/share, with turnover of $67.12 million. The gain was driven by a landmark favorable vote from the FDA's Medical Devices...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GRAIL Soars as FDA Panel Backs Galleri Cancer Test Approval","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669349596","title":"TD ups Grail approval probability to 95% after panel vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2669349596","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669349596?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:20","pubTimestamp":1790256057,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Dan Brennan views the end result of the FDA panel meeting as solid for Grail (GRAL). The panel voted 7-2 with in favor of Galleri’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/td-ups-grail-approval-probability-to-95-after-panel-vote-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/td-ups-grail-approval-probability-to-95-after-panel-vote-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4588","LABU","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":128,"code":"91000000","status":"200"}]}}